273 related articles for article (PubMed ID: 36933112)
1. Cholestatic Pruritus Treatments in Primary Biliary Cholangitis and Primary Sclerosing Cholangitis: A Systematic Literature Review.
Smith HT; de Souza AR; Thompson AH; McLaughlin MM; Dever JJ; Myers JA; Chen JV
Dig Dis Sci; 2023 Jun; 68(6):2710-2730. PubMed ID: 36933112
[TBL] [Abstract][Full Text] [Related]
2. Fibrates for Itch (FITCH) in Fibrosing Cholangiopathies: A Double-Blind, Randomized, Placebo-Controlled Trial.
de Vries E; Bolier R; Goet J; Parés A; Verbeek J; de Vree M; Drenth J; van Erpecum K; van Nieuwkerk K; van der Heide F; Mostafavi N; Helder J; Ponsioen C; Oude Elferink R; van Buuren H; Beuers U;
Gastroenterology; 2021 Feb; 160(3):734-743.e6. PubMed ID: 33031833
[TBL] [Abstract][Full Text] [Related]
3. Fibrates for the treatment of cholestatic itch (FITCH): study protocol for a randomized controlled trial.
Bolier R; de Vries ES; Parés A; Helder J; Kemper EM; Zwinderman K; Elferink RPO; Beuers U;
Trials; 2017 May; 18(1):230. PubMed ID: 28535810
[TBL] [Abstract][Full Text] [Related]
4. Effect of ileal bile acid transporter inhibitor GSK2330672 on pruritus in primary biliary cholangitis: a double-blind, randomised, placebo-controlled, crossover, phase 2a study.
Hegade VS; Kendrick SF; Dobbins RL; Miller SR; Thompson D; Richards D; Storey J; Dukes GE; Corrigan M; Oude Elferink RP; Beuers U; Hirschfield GM; Jones DE
Lancet; 2017 Mar; 389(10074):1114-1123. PubMed ID: 28187915
[TBL] [Abstract][Full Text] [Related]
5. Pathogenesis and Management of Pruritus in PBC and PSC.
Kremer AE; Namer B; Bolier R; Fischer MJ; Oude Elferink RP; Beuers U
Dig Dis; 2015; 33 Suppl 2():164-75. PubMed ID: 26641452
[TBL] [Abstract][Full Text] [Related]
6. Fibrates for the treatment of pruritus in primary biliary cholangitis: a systematic review and meta-analysis.
Shen N; Pan J; Miao H; Zhang H; Xing L; Yu X
Ann Palliat Med; 2021 Jul; 10(7):7697-7705. PubMed ID: 34353058
[TBL] [Abstract][Full Text] [Related]
7. Prospective evaluation of PBC-specific health-related quality of life questionnaires in patients with primary sclerosing cholangitis.
Raszeja-Wyszomirska J; Wunsch E; Krawczyk M; Rigopoulou EI; Bogdanos D; Milkiewicz P
Liver Int; 2015 Jun; 35(6):1764-71. PubMed ID: 25388280
[TBL] [Abstract][Full Text] [Related]
8. Complications, symptoms, quality of life and pregnancy in cholestatic liver disease.
Zakharia K; Tabibian A; Lindor KD; Tabibian JH
Liver Int; 2018 Mar; 38(3):399-411. PubMed ID: 28921801
[TBL] [Abstract][Full Text] [Related]
9. BAT117213: Ileal bile acid transporter (IBAT) inhibition as a treatment for pruritus in primary biliary cirrhosis: study protocol for a randomised controlled trial.
Hegade VS; Kendrick SF; Dobbins RL; Miller SR; Richards D; Storey J; Dukes G; Gilchrist K; Vallow S; Alexander GJ; Corrigan M; Hirschfield GM; Jones DE
BMC Gastroenterol; 2016 Jul; 16(1):71. PubMed ID: 27431238
[TBL] [Abstract][Full Text] [Related]
10. Novel Aspects in the Management of Cholestatic Liver Diseases.
Chazouillères O
Dig Dis; 2016; 34(4):340-6. PubMed ID: 27170387
[TBL] [Abstract][Full Text] [Related]
11. [Autoimmune mediated cholestatic liver diseases].
Mayer LS; Käser R; Böttler T
Dtsch Med Wochenschr; 2020 Mar; 145(5):296-305. PubMed ID: 32120404
[TBL] [Abstract][Full Text] [Related]
12. Chronic cholestatic liver diseases - Primary biliary cholangitis and Primary sclerosing cholangitis.
Fejfar T; Vaňásek T; Hůlek P
Vnitr Lek; 2020; 66(5):287-300. PubMed ID: 32942866
[TBL] [Abstract][Full Text] [Related]
13. Safety, tolerability, and efficacy of maralixibat in adults with primary sclerosing cholangitis: Open-label pilot study.
Bowlus CL; Eksteen B; Cheung AC; Thorburn D; Moylan CA; Pockros PJ; Forman LM; Dorenbaum A; Hirschfield GM; Kennedy C; Jaecklin T; McKibben A; Chien E; Baek M; Vig P; Levy C
Hepatol Commun; 2023 Jun; 7(6):. PubMed ID: 37184523
[TBL] [Abstract][Full Text] [Related]
14. Safety of fibrates in cholestatic liver diseases.
Carrion AF; Lindor KD; Levy C
Liver Int; 2021 Jun; 41(6):1335-1343. PubMed ID: 33751787
[TBL] [Abstract][Full Text] [Related]
15. Autoimmune biliary diseases: primary biliary cholangitis and primary sclerosing cholangitis.
Sarcognato S; Sacchi D; Grillo F; Cazzagon N; Fabris L; Cadamuro M; Cataldo I; Covelli C; Mangia A; Guido M
Pathologica; 2021 Jun; 113(3):170-184. PubMed ID: 34294935
[TBL] [Abstract][Full Text] [Related]
16. Primary sclerosing cholangitis response to the combination of fibrates with ursodeoxycholic acid: French-Spanish experience.
Lemoinne S; Pares A; Reig A; Ben Belkacem K; Kemgang Fankem AD; Gaouar F; Poupon R; Housset C; Corpechot C; Chazouillères O
Clin Res Hepatol Gastroenterol; 2018 Dec; 42(6):521-528. PubMed ID: 30100231
[TBL] [Abstract][Full Text] [Related]
17. The potent bile acid sequestrant colesevelam is not effective in cholestatic pruritus: results of a double-blind, randomized, placebo-controlled trial.
Kuiper EM; van Erpecum KJ; Beuers U; Hansen BE; Thio HB; de Man RA; Janssen HL; van Buuren HR
Hepatology; 2010 Oct; 52(4):1334-40. PubMed ID: 20683930
[TBL] [Abstract][Full Text] [Related]
18. Medical treatment of primary biliary cirrhosis and primary sclerosing cholangitis.
Holtmeier J; Leuschner U
Digestion; 2001; 64(3):137-50. PubMed ID: 11786661
[TBL] [Abstract][Full Text] [Related]
19. Biliary tract inflammatory disorders: primary sclerosing cholangitis and primary biliary cirrhosis.
Franco J; Saeian K
Curr Gastroenterol Rep; 1999 Apr; 1(2):95-101. PubMed ID: 10980934
[TBL] [Abstract][Full Text] [Related]
20. Management of Pruritus in Primary Biliary Cholangitis: A Narrative Review.
Trivedi HD; Lizaola B; Tapper EB; Bonder A
Am J Med; 2017 Jun; 130(6):744.e1-744.e7. PubMed ID: 28238692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
